Efficacy Results From the Antibody Mediated Prevention Trials for HIV Prevention: From the Bench to the Clinic and Back

Srilatha Edupuganti, MD, MPH, is an associate professor of infectious diseases at Emory University, where she leads HIV vaccine development as the Hope Clinic Clinical Research Site Leader for the Emory Clinical Trials Unit. She has a broad interest in vaccine development for multiple pathogens, including flaviviruses, influenza, and COVID-19, and she leads multiple translational vaccine immunology studies.

Edupuganti served in infectious diseases fellowships at Emory and at UNC, where she earned her MPH in epidemiology and joined the faculty, before moving to Emory in 2006.